UNIVERSITY OF BASEL Overweight increases the risk of an imbalance in sugar metabolism and even of diabetes. A research group at the University of Basel has now shown the opposite is true as well: deficits in the body’s insulin production contribute to overweight. Poor nutrition, too little movement and too many pounds on the scale...
Category: <span>Diabetes</span>
Post
SMNDC1 loss induces alpha cells to produce insulin
CEMM RESEARCH CENTER FOR MOLECULAR MEDICINE OF THE AUSTRIAN ACADEMY OF SCIENCES IMAGE: IMMUNOFLUORESCENCE IMAGES OF ALPHA CELLS HIGHLIGHTING INDUCTION OF INSULIN PROTEIN UPON LOSS OF SMNDC1 CREDIT: TAMARA CASTEELS, PUBLISHED IN CELL REPORT 2022. Beta cells in the pancreas are responsible for producing the vital hormone insulin. In diabetes, these cells are either destroyed...
Post
Breakthrough results in developing an oral insulin tablet
by University of British Columbia Optimization of parameters for insulin NPs: (a) Effect of the pH on the average diameter and the encapsulation efficiency (EE) of the insulin NPs (prepared under the mass ratio of chitosan and insulin at 5:1); (b) Effect of the mass ratio between chitosan and insulin the average diameter and the...
Post
Researchers closer to treating heart disease in diabetic patients
by University of Otago Graphical abstract. Credit: Molecular Therapy – Nucleic Acids (2022). DOI: 10.1016/j.omtn.2022.07.007 University of Otago researchers are closer to preventing immature death and improving the overall health of people with diabetes. More than 60% of people worldwide with type 2 diabetes die from some sort of heart disease. Associate Professor Rajesh Katare, of the Department...
Post
Youth-onset type 2 diabetes study reveals 77% increase during COVID-19 pandemic
CHILDREN’S HOSPITAL COLORADO “It used to be rare to hear about a child with type 2 diabetes, but its prevalence in adolescents has almost doubled in the past 20 years,” said Dr. Kesley. “Type 2 diabetes is associated with rapidly progressive disease and early onset of complications and, unfortunately, was on the rise even prior...
Post
Clinical trial offers more than a glimpse into eye treatments
by Queen’s University Belfast Credit: Unsplash/CC0 Public Domain A new clinical trial researching treatment for patients with sight loss as a result of diabetes has shown a type of laser treatment to be both cost effective and non-invasive, offering the best option for patients and health care providers. There are currently several treatment options offered...
Post
An apple a day on doctors’ orders keeps ill health away
by Imperial College London Credit: Pixabay/CC0 Public Domain Fresh fruit and vegetables prescribed by doctors could be an effective way to improve the health of Australians with type 2 diabetes, according to a new study published today in the Journal of Nutrition. Researchers at The George Institute for Global Health and UNSW Sydney found that people...
Post
Detection of rare genetic mutation in one family could lead to better diabetes treatments
by University of Utah Health Sciences Pedigree of the family enriched for diabetes and end-stage renal disease and identification of the ADIPOQ mutation. a The family pedigree, status of diabetes (shaded) and end-stage renal disease (ESRD; red outline), and the ADIPOQ mutation (p.Gly93GlufsTer73). Carriers of the wild-type ADIPOQ insertion (I) or mutated ADIPOQ deletion (D; red) are indicated. b The structure of the wild-type (top) and...
Post
Detecting diabetes before the first symptoms appear
by University of Geneva When diabetes starts to develop but no symptoms are yet detectable, part of the beta cells of the pancreas (in green) disappear (right image) compared to a healthy individual (left image). This previously undetectable decrease could be identified by measuring the level of 1,5-anhydroglucitol in the blood. Credit: UNIGE – Laboratory...
Post
DyAnsys Neurostimulation Device Approved for Neuropathic Pain
BY QUINN PHILLIPS | JANUARY 1, 1970 The U.S. Food and Drug Administration (FDA) has approved a neurostimulation device from DyAnsys, Inc., to treat pain related to diabetic peripheral neuropathy, according to a press release from the company. The newly approved device, called First Relief, is what’s known as a PENS (percutaneous electrical neurostimulation) device. That means...